We are live on ! Find out more
SYNB

Putnam BioRevolution ETF

Delisted

SYNB was delisted on the 13th of November, 2025.

5 hedge funds and large institutions have $4.36M invested in Putnam BioRevolution ETF in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

25% more funds holding

Funds holding: 45 (+1)

22% more capital invested

Capital invested by funds: $3.58M → $4.36M (+$777K)

11.11% more ownership

Funds ownership: 72.3%83.41% (+11%)

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Franklin Resources
1
Franklin Resources
California
$3.59M -$148K -5,000 -4%
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$389K +$341K +11,508 +759%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$357K +$353K +11,931 New
UBS Group
4
UBS Group
Switzerland
$30.3K +$29.6K +1,000 +7,692%
Osaic Holdings
5
Osaic Holdings
Arizona
$60

SYNB Hedge Fund Activity: Q3 2025 in Review

5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q3 2025, worth a combined $4.36M — up 22% from $3.58M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new SYNB positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $353K. The largest seller was Franklin Resources, cutting an estimated $148K.

  • 5 institutional investors held Putnam BioRevolution ETF (SYNB) as of Q3 2025, up from 4 in Q2 2025.
  • Funds reported $4.36M of Putnam BioRevolution ETF stock for Q3 2025, up 22% quarter-over-quarter.
  • 1 fund opened new Putnam BioRevolution ETF positions in Q3 2025 and 0 closed out, a net change of +1 holder.
  • The largest Putnam BioRevolution ETF buyer in Q3 2025 was Susquehanna International Group, an estimated $353K added.
  • The largest Putnam BioRevolution ETF seller in Q3 2025 was Franklin Resources, an estimated $148K sold.

Based on aggregated 13F filings for Q3 2025.